Clinical prognostic factors in multiple sclerosis: A natural history review

Nature Reviews Neurology

Volumn 5, Issue 12, 2009, Pages 672-682

  Degenhardt, Alexandra ^a   Ramagopalan, Sreeram V ^a   Scalfari, Antonio ^a   Ebers, George C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; GLATIRAMER; INTERFERON; METHOTREXATE; MITOXANTRONE; STEROID;

BIRTH; DISABILITY; DISEASE COURSE; ETHNICITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MULTIPLE SCLEROSIS; ONSET AGE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVIEW; SEX DIFFERENCE; SURVIVAL TIME; SYMPTOMATOLOGY;

DATABASES, FACTUAL; DISABILITY EVALUATION; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 74949120123     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.178     Document Type: Review

References (92)

1. Ebers, G. in McAlpine's Multiple Sclerosis 3rd edn (eds Compston, A., Ebers, G., Lassmann, H., McDonald, I., Matthews, B. & Wekerle, H.) 191-223 (Churchill Livingstone, London, 1998).
2. Weinshenker, B. G. & Ebers, G. C. The natural history of multiple sclerosis. Can. J. Neurol. Sci. 14, 255-261 (1987).
3. Ascherio, A. in Neuroepidemiology (eds Nelson, L. M., Tanner, C. M., van Den Eeden, S. & McGuire v. M.) 188-223 (Oxford University Press, Oxford, 2004).
4. Noseworthy, J. H, Van Der Voort, M. K., Wong, C. J. & Ebers, G. C. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 40, 971-975 (1990).
5. Goodkin, D. E. et al. Inter-and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology 42, 859-863 (1992).
6. Kurtzke, J. F. et al. Studies on natural history of multiple sclerosis. 4. Clinical features of the onset bout. Acta Neurol. Scand. 44, 467-494 (1968).
7. Detels, R. et al. Factors associated with a rapid course of multiple sclerosis. Arch. Neurol. 39, 337-341 (1982).
8. Kurtzke, J. F. & Page, W. F. Epidemiology of multiple sclerosis in US veterans: vII. Risk factors for MS. Neurology 48, 204-213 (1997).
9. Bronnum-Hansen, H., Koch-Henriksen, N. & Hyllested, K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology 44, 1901-1907 (1994).
10. Riise, T. et al. Prognostic factors for life expectancy in multiple sclerosis analysed by Coxmodels. J. Clin. Epidemiol. 41, 1031-1036 (1988).
11. Poser, S. et al. Prognostic indicators in multiple sclerosis. Acta Neurol. Scand. 74, 387-392 (1986).
12. Phadke, J. G. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 113, 1597-1628 (1990).
13. Weinshenker, B. et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112, 133-146 (1989). (Pubitemid 19056478)
14. Svenningsson, A., Runmarker, B., Lycke, J. & Andersen, O. Incidence of MS during two fifteenyear periods in the Gothenburg region of Sweden. Acta Neurol. Scand. 82, 161-168 (1990).
15. Amato, M. P., Ponziani, G., Bartolozzi, M. L. & Siracusa, G. A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. J. Neurol. Sci. 168, 96-106 (1999).
16. Confavreux, C., Aimard, G. & Devic, M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103, 281-300 (1980).
17. Sumelahti, M. L., Tienari, P. J., Wikstrom, J., Salminen, T. M. & Hakama, M. Survival of multiple sclerosis in Finland between 1964 and 1993. Mult. Scler. 8, 350-355 (2002).
18. Miller, D. H., Hornabrook, R. W. & Purdie, G. The natural history of multiple sclerosis: a regional study with some longitudinal data. J. Neurol. Neurosurg. Psychiatry 55, 341-346 (1992).
19. Lublin, F. D. & Reingold, S. C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46, 907-911 (1996).
20. Kremenchutzky, M. et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsingprogressive multiple sclerosis: a re-evaluation. Brain 122, 1941-1950 (1999).
21. Kurtzke, J. F., Beebe, G. W., Nagler, B., Kurland, L. T. & Auth, T. L. Studies on the natural history of multiple sclerosis-8. Early prognostic features of the later course of the illness. J. Chronic Dis. 30, 819-830 (1977).
22. Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452 (1983).
23. vukusic, S. & Confavreux, C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J. Neurol. Sci. 206, 135-137 (2003).
24. vukusic, S. & Confavreux, C. Primary and secondary progressive multiple sclerosis. J. Neurol. Sci. 206, 153-155 (2003).
25. Confavreux, C., vukusic, S. & Adeleine, P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126, 770-782 (2003).
26. Confavreux, C. & vukusic, S. Age at disability milestones in multiple sclerosis. Brain 129, 595-605 (2006).
27. Confavreux, C. & vukusic, S. Natural history of multiple sclerosis: a unifying concept. Brain 129, 606-616 (2006). (Pubitemid 43278223)
28. Confavreux, C., vukusic, S., Moreau, T. & Adeleine, P. Relapses and progression of disability in multiple sclerosis. N. Engl. J. Med. 343, 1430-1438 (2000).
29. Poser, C. M. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231 (1983).
30. Schumacher, G. A. et al. Problems of experimental trial of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann. NY Acad. Sci. 122, 522-568 (1965).
31. Kurtzke, J. F., Beebe, G. W. & Norman, J. E. Jr. Epidemiology of multiple sclerosis in U. S. veterans: 1. Race, sex, and geographic distribution. Neurology 29, 1228-1235 (1979).
32. Kurtzke, J. F. et al. Studies on the natural history of multiple sclerosis. v. Long-term survival in young men. Arch. Neurol. 22, 215-225 (1970).
33. Nagler, B. et al. Studies on the natural history of multiple sclerosis. 1. Design and diagnosis. Acta Neurol. Scand. 42 (Suppl. 19), 141-156 (1966).
34. Beebe, G. W., Kurtzke, J. F., Kurland, L. T., Auth, T. L. & Nagler, B. Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II. Neurology 17, 1-17 (1967).
35. Kurtzke, J. F. et al. Studies on the natural history of multiple sclerosis. 6. Clinical and laboratory findings at first diagnosis. Acta Neurol. Scand. 48, 19-46 (1972).
36. Wallin, M. T., Page, W. F. & Kurtzke, J. F. Epidemiology of multiple sclerosis in US veterans. vIII. Long-term survival after onset of multiple sclerosis. Brain 123, 1677-1687 (2000).
37. Runmarker, B. & Andersen, O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116, 117-134 (1993).
38. Eriksson, M., Andersen, O. & Runmarker, B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult. Scler. 9, 260-274 (2003).
39. Broman, T., Andersen, O. & Bergmann, L. Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg. Acta Neurol. Scand. 63, 6-33 (1981).
40. Gudmundsson, K. R. Clinical studies of multiple sclerosis in Iceland. A follow-up of previous survey and reappraisal. Acta Neurol. Scand. 48 (Suppl.), 1-78 (1971).
41. Benedikz, J. et al. The natural history of untreated multiple sclerosis in Iceland. A total populationbased 50 year prospective study. Clin. Neurol. Neurosurg. 104, 208-210 (2002).
42. Poser, S., Bauer, H. J. & Poser, W. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany. Acta Neurol. Scand. 65, 347-354 (1982).
43. Bauer, H. J., Poser, S. & Ritter, G. (Eds) Progress in Multiple Sclerosis Research (Springer verlag, Berlin, 1980).
44. Weinshenker, B. G. et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112, 1419-1428 (1989).
45. Cottrell, D. A. et al. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122, 641-647 (1999).
46. Cottrell, D. A. et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122, 625-639 (1999).
47. Ebers, G. C. Natural history of primary progressive multiple sclerosis. Mult. Scler. 10 (Suppl. 1), S8-S13 (2004).
48. Kremenchutzky, M., Rice, G. P., Baskerville, J., Wingerchuk, D. M. & Ebers, G. C. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 129, 584-594 (2006).
49. Lauer, K. & Firnhaber, W. Epidemiological investigations into multiple sclerosis in Southern Hesse. v. Course and prognosis. Acta Neurol. Scand. 76, 12-17 (1987).
50. Clark, V. A. et al. Factors associated with a malignant or benign course of multiple sclerosis. JAMA 248, 856-860 (1982).
51. visscher, B. R. et al. Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol. Scand. 70, 321-328 (1984).
52. McDonnell, G. V. & Hawkins, S. A. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 50, 423-428 (1998).
53. McDonnell, G. V. & Hawkins, S. A. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J. Neurol. Neurosurg. Psychiatry 64, 451-454 (1998).
54. Hawkins, S. A. & McDonnell, G. V. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J. Neurol. Neurosurg. Psychiatry 67, 148-152 (1999).
55. Mayr, W. T. et al. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 61, 1373-1377 (2003).
56. Pittock, S. J. et al. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 62, 51-59 (2004).
57. Pittock, S. J. et al. Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology 62, 601-606 (2004).
58. Rodriguez, M. et al. Impairment, disability, and handicap in multiple sclerosis: a populationbased study in Olmsted County, Minnesota. Neurology 44, 28-33 (1994).
59. Alter, M. et al. Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants. Arch. Neurol. 7, 253-263 (1962).
60. Alter, M., Leibowitz, U. & Halpern, L. Clinical studies of multiple sclerosis in Israel. II. A comparison between European and Afro-Asian Patients. J. Neurol. Neurosurg. Psychiatry 27, 522-529 (1964).
61. Leibowitz, U., Alter, M. & Halpern, L. Clinical studies of multiple sclerosis in Israel. 3. Clinical course and prognosis related to age at onset. Neurology 14, 926-932 (1964).
62. Leibowitz, U., Halpern, L. & Alter, M. Clinical studies of multiple sclerosis in Israel. I. A clinical analysis based on a country-wide survey. Arch. Neurol. 10, 502-512 (1964).
63. Leibowitz, U., Kahana, E. & Alter, M. Survival and death in multiple sclerosis. Brain 92, 115-130 (1969).
64. Leibowitz, U. & Alter, M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol. Scand. 46, 53-70 (1970).
65. Kahana, E., Leibowitz, U. & Alter, M. Brainstem and cranial nerve involvement in multiple sclerosis. Acta Neurol. Scand. 49, 269-279 (1973).
66. Tremlett, H., Paty, D. & Devonshire, v. The natural history of primary progressive MS in British Columbia, Canada. Neurology 65, 1919-1923 (2005).
67. Tremlett, H., Paty, D. & Devonshire, V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 66, 172-177 (2006).
68. Minderhoud, J. M., van der Hoeven, J. H. & Prange, A. J. Course and prognosis of chronic progressive multiple sclerosis. Acta Neurol. Scand. 78, 10-15 (1988).
69. Ramsaransing, G. S. & De Keyser, J. Predictive value of clinical characteristics for 'benign' multiple sclerosis. Eur. J. Neurol. 14, 885-889 (2007).
70. Sundstrom, P., Nystrom, L. & Forsgren, L. Incidence (1988-1997) and prevalence (1997) of multiple sclerosis in vasterbotten County in northern Sweden. J. Neurol. Neurosurg. Psychiatry 74, 29-32 (2003). (Pubitemid 36069032)
71. Sundstrom, P., Svenningsson, A., Nystrom, L. & Forsgren, L. Clinical characteristics of multiple sclerosis in vasterbotten County in northern Sweden. J. Neurol. Neurosurg. Psychiatry 75, 711-716 (2004).
72. Bronnum-Hansen, H., Koch-Henriksen, N. & Stenager, E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 127, 844-850 (2004).
73. Leray, E. et al. Long-term survival of patients with multiple sclerosis in West France. Mult. Scler. 13, 865-874 (2007).
74. Myhr, K. M. et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult. Scler. 7, 59-65 (2001).
75. Midgard, R., Albrektsen, G., Riise, T., Kvale, G. & Nyland, H. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in More and Romsdal, Norway. J. Neurol. Neurosurg. Psychiatry 58, 417-421 (1995).
76. Pekmezovic, T., Jarebinski, M., Drulovic, J., Stojsavljevic, N. & Levic, Z. Prevalence of multiple sclerosis in Belgrade, Yugoslavia. Acta Neurol. Scand. 104, 353-357 (2001).
77. Phadke, J. G. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J. Neurol. Neurosurg. Psychiatry 50, 523-531 (1987).
78. Pekmezovic, T., Jarebinski, M., Drulovic, J., Stojsavljevic, N. & Levic, Z. Survival of multiple sclerosis patients in the Belgrade population. Neuroepidemiology 21, 235-240 (2002).
79. Shepherd, D. I. Clinical features of multiple sclerosis in north-east Scotland. Acta Neurol. Scand. 60, 218-230 (1979).
80. Koch-Henriksen, N., Bronnum-Hansen, H. & Stenager, E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J. Neurol. Neurosurg. Psychiatry 65, 56-59 (1998).
81. Sadovnick, A. D., Eisen, K., Ebers, G. C. & Paty, D. W. Cause of death in patients attending multiple sclerosis clinics. Neurology 41, 1193-1196 (1991).
82. Sadovnick, A. D., Ebers, G. C., Wilson, R. W. & Paty, D. W. Life expectancy in patients attending multiple sclerosis clinics. Neurology 42, 991-994 (1992).
83. Hammond, S. R., McLeod, J. G., Macaskill, P. & English, D. R. Multiple sclerosis in Australia: prognostic factors. J. Clin. Neurosci. 7, 16-19 (2000).
84. Weinshenker, B. G. et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114, 1045-1056 (1991).
85. Thompson, D. S., Nelson, L. M., Burns, A., Burks, J. S. & Franklin, G. M. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 36, 1097-1099 (1986).
86. Weinshenker, B. G., Hader, W., Carriere, W., Baskerville, J. & Ebers, G. C. The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 39, 1438-1440 (1989).
87. Poser, S. & Poser, W. Multiple sclerosis and gestation. Neurology 33, 1422-1427 (1983).
88. Runmarker, B. & Andersen, O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118, 253-261 (1995).
89. Roullet, E. et al. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J. Neurol. Neurosurg. Psychiatry 56, 1062-1065 (1993).
90. Ghezzi, A. et al. Prospective study of multiple sclerosis with early onset. Mult. Scler. 8, 115-118 (2002).
91. Boiko, A. et al. Early onset multiple sclerosis: a longitudinal study. Neurology 59, 1006-1010 (2002).
92. Noseworthy, J., Paty, D., Wonnacott, T., Feasby, T. & Ebers, G. Multiple sclerosis after age 50. Neurology 33, 1537-1544 (1983).